Open access · CC-BY
via OpenAlex
mTORC2: The other mTOR in autophagy regulation
Josué Ballesteros‐Álvarez, Julie Kay Andersen
Aging Cell · 2021 · ▲ 187 citations
Abstract
The mechanistic target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) (mTOR) has gathered significant attention as a ubiquitously expressed multimeric kinase with key implications for cell growth, proliferation, and survival. This kinase forms the central core of two distinct complexes, mTORC1 and mTORC2, which share the ability of integrating environmental, nutritional, and hormonal cues but which regulate separate molecular pathways that result in different cellular responses. Particularly, mTORC1 has been described as a major negative regulator of endosomal biogenesis and autophagy(definition), a catabolic process that degrades intracellular components and organelles within the lysosomes and is thought to play a key role in human health and disease. In contrast, the role of mTORC2 in the regulation of autophagy has been considerably less studied despite mounting evidence this complex may regulate autophagy in a different and perhaps complementary manner to that of mTORC1. Genetic ablation of unique subunits is currently being utilized to study the differential effects of the two mTOR complexes. RICTOR is the best-described subunit specific to mTORC2 and as such has become a useful tool for investigating the specific actions of this complex. The development of complex-specific inhibitors for mTORC2 is also an area of intense interest. Studies to date have demonstrated that mTORC1/2 complexes each signal to a variety of exclusive downstream molecules with distinct biological roles. Pinpointing the particular effects of these downstream effectors is crucial toward the development of novel therapies aimed at accurately modulating autophagy in the context of human aging and disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/acel.13431
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Ballesteros‐Álvarez, J., & Andersen, J.K. (2021). mTORC2: The other mTOR in autophagy regulation. <em>Aging Cell</em>. https://doi.org/10.1111/acel.13431
Vancouver
Ballesteros‐Álvarez J, Andersen JK. mTORC2: The other mTOR in autophagy regulation. Aging Cell. 2021. doi:10.1111/acel.13431.
BibTeX
@article{josu2021mTORCT,
title = {mTORC2: The other mTOR in autophagy regulation},
author = {Josué Ballesteros‐Álvarez and Julie Kay Andersen},
journal = {Aging Cell},
year = {2021},
doi = {10.1111/acel.13431},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cold Spring Harbor Perspectives in Biology 2012
Preprint · OA
mTOR-Dependent Cell Survival Mechanisms
BMB Reports 2011
Open access · CC-BY
The functions of mTOR in ischemic diseases
International Journal of Molecular Sciences 2018
Open access · CC-BY
The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis
Biochemical Journal 2024
Open access · CC-BY
The mTORC2 signaling network: targets and cross-talks
Biochemical Society Transactions 2013
Citation only
Adaptation to chronic mTOR inhibition in cancer and in aging
Aging Cell 2013
Open access · CC-BY